- Home
- ORIC vs MUJ Comparison
ORIC vs MUJ Comparison
Compare ORIC & MUJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- MUJ
- Stock Information
- Founded
- ORIC 2014
- MUJ 1998
- Country
- ORIC United States
- MUJ United States
- Employees
- ORIC N/A
- MUJ N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- MUJ Investment Bankers/Brokers/Service
- Sector
- ORIC Health Care
- MUJ Finance
- Exchange
- ORIC Nasdaq
- MUJ Nasdaq
- Market Cap
- ORIC 1.1B
- MUJ 619.6M
- IPO Year
- ORIC 2020
- MUJ N/A
- Fundamental
- Price
- ORIC $12.24
- MUJ $11.83
- Analyst Decision
- ORIC Strong Buy
- MUJ
- Analyst Count
- ORIC 8
- MUJ 0
- Target Price
- ORIC $16.57
- MUJ N/A
- AVG Volume (30 Days)
- ORIC 1.3M
- MUJ 108.0K
- Earning Date
- ORIC 11-06-2025
- MUJ 01-01-0001
- Dividend Yield
- ORIC N/A
- MUJ 4.36%
- EPS Growth
- ORIC N/A
- MUJ N/A
- EPS
- ORIC N/A
- MUJ N/A
- Revenue
- ORIC N/A
- MUJ N/A
- Revenue This Year
- ORIC N/A
- MUJ N/A
- Revenue Next Year
- ORIC N/A
- MUJ N/A
- P/E Ratio
- ORIC N/A
- MUJ N/A
- Revenue Growth
- ORIC N/A
- MUJ N/A
- 52 Week Low
- ORIC $3.90
- MUJ $9.74
- 52 Week High
- ORIC $14.93
- MUJ $11.70
- Technical
- Relative Strength Index (RSI)
- ORIC 46.59
- MUJ 72.93
- Support Level
- ORIC $12.75
- MUJ $11.59
- Resistance Level
- ORIC $13.57
- MUJ $11.85
- Average True Range (ATR)
- ORIC 0.70
- MUJ 0.08
- MACD
- ORIC -0.17
- MUJ 0.01
- Stochastic Oscillator
- ORIC 25.12
- MUJ 97.14
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.
BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.